Results 241 to 250 of about 1,809,039 (333)
Extended producer responsibility and comparative advantage
Michael J. Augusteijn
openalex +1 more source
Research on the Comparative Advantage of Blockchain Payment Systems
Liang-Xin Li, Zehan Li
openalex +1 more source
Economic Linkages and Comparative Advantage of the UK Creative Sector
Zhen Ye, Ya Ping Yin
openalex +2 more sources
ABSTRACT Objective Glioma recurrence severely impacts patient prognosis, with current treatments showing limited efficacy. Traditional methods struggle to analyze recurrence mechanisms due to challenges in assessing tumor heterogeneity, spatial dynamics, and gene networks.
Lei Qiu +10 more
wiley +1 more source
A comparative study on DeepSeek and ChatGPT for bone and soft tissue tumor clinical practice. [PDF]
Yang B +6 more
europepmc +1 more source
Travel service exports as comparative advantage in South Africa
Johan Fourie
openalex +2 more sources
ABSTRACT Objectives WHO grade 4 astrocytomas are associated with poor prognosis, and their prognostic factors remain controversial. This study aimed to identify the prognostic factors and develop a management algorithm for these patients. Methods This study retrospectively included 151 CNS5 adult grade 4 astrocytomas from two medical centers.
Jiawei Cai +13 more
wiley +1 more source
Simultaneous Pancreas-Kidney Versus Kidney Transplant Alone: Real-World Outcomes in a Propensity-Matched Global Cohort. [PDF]
Catarinella D +4 more
europepmc +1 more source
Remote Assessment of Ataxia Severity in SCA3 Across Multiple Centers and Time Points
ABSTRACT Objective Spinocerebellar ataxia type 3 (SCA3) is a genetically defined ataxia. The Scale for Assessment and Rating of Ataxia (SARA) is a clinician‐reported outcome that measures ataxia severity at a single time point. In its standard application, SARA fails to capture short‐term fluctuations, limiting its sensitivity in trials.
Marcus Grobe‐Einsler +20 more
wiley +1 more source

